slides · global inventory
47 Quick Win Big Bet
Loop collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 9,718
Current window 5,131-5,160
Pages 324
Rows per page 30
Loop
5,131-5,160 of 9,718
36
Uses a funnel framework to show the narrowing of research from broad data to specific targets.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
37
23andMe | Investor Presentation Deck | 57 slides23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
38
The slide uses a process flow to connect market size to proprietary methodology and specific pipeline assets.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
39
23andMe | Investor Presentation Deck | 57 slides23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
40
The slide uses heatmaps to show genetic associations, contrasting immune and cancer phenotypes for specific proteins.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
41
Includes a biological pathway diagram illustrating the interaction between tumor cells and immune cells.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
42
The slide uses a before-and-after diagram to illustrate the mechanism of action.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
43
The chart shows a scatter plot with a regression line indicating a correlation coefficient (rho) of 0.86.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
44
Data shows 23ME '610 consistently outperforms isotype control and anti-PD1 in IFNy production across most tested cancer types.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
45
The slide uses a process flow diagram to illustrate the study design (Part A to Part B).23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
46
The slide outlines the mechanism of action, clinical rationale, and upcoming Phase 2a study design for the drug candidate.23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
47
23andMe | Investor Presentation Deck | 57 slides23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
48
23andMe | Investor Presentation Deck | 57 slides23andMe | Investor Presentation Deck | 57 slides · 23andMe
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
16
Shows two facility locations with brief status updates.Arrival | SPAC Presentation Deck | 21 slides · Arrival
Pitch deck Investment bank Loop · Quick Win Big Bet1 hit
17
Arrival | SPAC Presentation Deck | 21 slidesArrival | SPAC Presentation Deck | 21 slides · Arrival
Pitch deck Investment bank Loop · Quick Win Big Bet1 hit
08
Slide presents a press release excerpt as evidence of commercial/government traction.Astra | Investor Presentation Deck | 63 slides · Astra
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
16
Includes Kaplan-Meier survival curves and bar charts for pCR rates.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
17
Slide 17 of a presentation deck. Includes detailed technical footnotes.AstraZeneca | Results Presentation Deck | 41 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
20
Includes a footnote explaining pro forma vs reported revenue.Crocs | Results Presentation Deck | 40 slides · Crocs
Conference presentation Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
10
The slide uses line charts to demonstrate performance trends over four years (Y1-Y4) for three distinct metrics.P3 Health Partners | Investor Conference Presentation Deck | 13 slides · P3 Health Partners
Conference presentation Investor relations Beat · The BreakthroughLoop · Before After1 hit
11
P3 branding in bottom right corner.P3 Health Partners | Investor Conference Presentation Deck | 13 slides · P3 Health Partners
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
12
Includes a disclaimer about non-GAAP reconciliation at the bottom.P3 Health Partners | Investor Conference Presentation Deck | 13 slides · P3 Health Partners
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
12
The slide uses a 2x2 grid layout to present four distinct strategic pillars.Reservoir | Investor Presentation Deck | 35 slides · Privia Health
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
13
The slide uses a 2x3 grid layout to present distinct market tailwinds.Reservoir | Investor Presentation Deck | 35 slides · Privia Health
Pitch deck Investor relations Loop · Why Now1 hit
14
The slide uses pie charts to show revenue mix shifts and a table to show CAGR and absolute revenue growth.Reservoir | Investor Presentation Deck | 35 slides · Privia Health
Pitch deck Investor relations Beat · Market SizeLoop · Why Now1 hit
15
The slide uses a table to list initiatives and a bubble chart to show growth performance.Reservoir | Investor Presentation Deck | 35 slides · Privia Health
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
16
The slide uses a split-layout to show commercial traction (synch deals) and industry influence (board seats).Reservoir | Investor Presentation Deck | 35 slides · Privia Health
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
17
The slide uses a funnel-like structure for the deal flow on the left and a summary of historical performance and pipeline on the right.Reservoir | Investor Presentation Deck | 35 slides · Privia Health
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
18
The table tracks purchase price, earnings (NPS/NLS), and multiples at close vs FY2022.Reservoir | Investor Presentation Deck | 35 slides · Privia Health
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
19
Includes a list of notable signings and the artists they have worked with.Reservoir | Investor Presentation Deck | 35 slides · Privia Health
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit